Physician profile
Kyle Mitts
NPI 1518372382
$3,436.17
in general payments reported to CMS, 2019-2025
14 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.37 · 2020: $389 · 2021: $723 · 2022: $839 · 2023: $760 · 2024: $414 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,385 · Education: $57.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.86 |
| Education | $57.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,069.90 | 2020-2025 | Scopis Ent |
| Inspire Medical Systems, INC. | $860.23 | 2023-2025 | Inspire |
| Advanced Bionics, LLC | $269.10 | 2022 | |
| Smith+Nephew, INC. | $217.97 | 2019-2020 | |
| Intersect Ent, INC. | $195.61 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $194.87 | 2022-2023 | Dupixent, Libtayo |
| Genzyme Corporation | $165.77 | 2022-2023 | |
| Medtronic, INC. | $165.40 | 2025 | Nuvent |
| Optinose US, INC. | $133.48 | 2022-2023 | |
| Glaxosmithkline, LLC. | $60.98 | 2022-2023 | Nucala |
| Phadia US INC. | $33.68 | 2022 | |
| Kaleo, INC. | $32.59 | 2021 | |
| Alk-Abello, INC | $23.39 | 2022 | |
| Hologic Sales and Service, LLC | $13.20 | 2023 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Mitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.